Search research articles
Contact Us
Filters
Showing results (331-340 of 374) with videos related to
Page
of 38
Sort By:
Blood
|
December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
F Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology
|
February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis
C Craddock, R M Szydlo, F Dazzi, et al.
Clinical Pharmacokinetics
|
August 20, 2016
Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence
Manfred Bodenlenz, Katrin I Tiffner, Reingard Raml, et al.
British Journal of Haematology
|
February 23, 1999
CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome
D Gupta, A Bybee, F Cooke, et al.
Bone Marrow Transplantation
|
March 10, 2015
Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party
K Horstmann, A Boumendil, J Finke, et al.
Bone Marrow Transplantation
|
February 28, 2006
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients
D O'Shea, C Giles, E Terpos, et al.
ACS Chemical Biology
|
August 2, 2017
Peptide-Membrane Interaction between Targeting and Lysis
Katharina Stutz, Alex T Müller, Jan A Hiss, et al.
Molecular Pharmaceutics
|
February 23, 2012
Provisional biopharmaceutical classification of some common herbs used in Western medicine
Sarah Waldmann, May Almukainzi, Nadia Araci Bou-Chacra, et al.
Leukemia
|
February 11, 2005
Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse
D Marin, J Kaeda, R Szydlo, et al.
British Journal of Haematology
|
December 12, 2001
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
T I Mughal, A Yong, R M Szydlo, et al.
Page
of 38
Search research articles
Search
Showing results (331-340 of 374) with videos related to
Sort By:
Page
of 38
Blood
|
December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
F Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology
|
February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis
C Craddock, R M Szydlo, F Dazzi, et al.
Clinical Pharmacokinetics
|
August 20, 2016
Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence
Manfred Bodenlenz, Katrin I Tiffner, Reingard Raml, et al.
British Journal of Haematology
|
February 23, 1999
CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome
D Gupta, A Bybee, F Cooke, et al.
Bone Marrow Transplantation
|
March 10, 2015
Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party
K Horstmann, A Boumendil, J Finke, et al.
Bone Marrow Transplantation
|
February 28, 2006
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients
D O'Shea, C Giles, E Terpos, et al.
ACS Chemical Biology
|
August 2, 2017
Peptide-Membrane Interaction between Targeting and Lysis
Katharina Stutz, Alex T Müller, Jan A Hiss, et al.
Molecular Pharmaceutics
|
February 23, 2012
Provisional biopharmaceutical classification of some common herbs used in Western medicine
Sarah Waldmann, May Almukainzi, Nadia Araci Bou-Chacra, et al.
Leukemia
|
February 11, 2005
Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse
D Marin, J Kaeda, R Szydlo, et al.
British Journal of Haematology
|
December 12, 2001
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse
T I Mughal, A Yong, R M Szydlo, et al.
Page
of 38